Background Coronary artery bypass grafting has been performed for a long period utilizing saphenous vein grafts, the fate of which might be crucial to prognosis following the operation. Metabolic syndrome, on the other hand, has become an increasingly important part of cardiovascular practice. We examined whether there was any negative effect of metabolic syndrome on saphenous vein graft patency in a relatively short term (<= 5 years)
AbstractObjectives. To determine the potential of lipid-lowering therapy to reduce saphenous vein gr...
Saphenous vein graft disease (SVGD) is a type of vascular disease that may develop after coronary ar...
Introduction: Diabetes Mellitus (DM) has been known to be a risk factor for the development of more ...
Background Coronary artery bypass grafting has been performed for a long period utilizing saphenous ...
Metabolic syndrome is a well-known cardiovascular risk factor closely related to increased insulin r...
Background. Metabolic syndrome (MetS) is frequently associated with coronary artery disease, but dat...
ObjectivesMetabolic syndrome is common among patients having coronary artery bypass grafting. Howeve...
Background: The prevalence of Metabolic syndrome (MetS) has been increased in Asian countries. It re...
ObjectivesThe aim of this study was to determine the impact of the metabolic syndrome (MS) on operat...
Background: The prevalence of Metabolic syndrome (MetS) has been increased in Asian countries. It re...
Background: Metabolic syndrome (MetS) is defined as a cluster of systemic abnormalities: hyperglycem...
Metabolic syndrome (MetS) and obesity are risk factors for cardiovascular disease, however, it remai...
Abstract Background Metabolic Syndrome and diabetes mellitus are risk factors for cardiovascular dis...
BACKGROUND: Metabolic syndrome (MetS) is a risk factor for cardiovascular disease and mortality, but...
<div><p>Background</p><p>Metabolic syndrome (MetS) and obesity are risk factors for cardiovascular d...
AbstractObjectives. To determine the potential of lipid-lowering therapy to reduce saphenous vein gr...
Saphenous vein graft disease (SVGD) is a type of vascular disease that may develop after coronary ar...
Introduction: Diabetes Mellitus (DM) has been known to be a risk factor for the development of more ...
Background Coronary artery bypass grafting has been performed for a long period utilizing saphenous ...
Metabolic syndrome is a well-known cardiovascular risk factor closely related to increased insulin r...
Background. Metabolic syndrome (MetS) is frequently associated with coronary artery disease, but dat...
ObjectivesMetabolic syndrome is common among patients having coronary artery bypass grafting. Howeve...
Background: The prevalence of Metabolic syndrome (MetS) has been increased in Asian countries. It re...
ObjectivesThe aim of this study was to determine the impact of the metabolic syndrome (MS) on operat...
Background: The prevalence of Metabolic syndrome (MetS) has been increased in Asian countries. It re...
Background: Metabolic syndrome (MetS) is defined as a cluster of systemic abnormalities: hyperglycem...
Metabolic syndrome (MetS) and obesity are risk factors for cardiovascular disease, however, it remai...
Abstract Background Metabolic Syndrome and diabetes mellitus are risk factors for cardiovascular dis...
BACKGROUND: Metabolic syndrome (MetS) is a risk factor for cardiovascular disease and mortality, but...
<div><p>Background</p><p>Metabolic syndrome (MetS) and obesity are risk factors for cardiovascular d...
AbstractObjectives. To determine the potential of lipid-lowering therapy to reduce saphenous vein gr...
Saphenous vein graft disease (SVGD) is a type of vascular disease that may develop after coronary ar...
Introduction: Diabetes Mellitus (DM) has been known to be a risk factor for the development of more ...